Skip to main content
. 2022 Jul 7;2022:4020550. doi: 10.1155/2022/4020550

Table 2.

Unadjusted mean and standard deviations scores at each time point.

Measured time point Treatment group mean (SD) Control group mean (SD)
Brief Pain Inventory-Interference
 T1 4.60 (2.39) 4.28 (2.40)
 T2 4.32 (2.37) 4.08 (2.39)
 T3 3.40 (2.34) 3.92 (2.61)
 T4 3.49 (2.09) 3.58 (2.61)
Profile of Mood States
 T1 67.42 (14.97) 62.72 (13.68)
 T2 65.04 (15.44) 63.21 (14.8)
 T3 61.42 (15.02) 63.37 (14.89)
 T4 62.88 (16.67) 60.92 (16.46)
Patient Global Impression of Change
 T1 N/A N/A
 T2 4.29 (1.14) 4.24 (.94)
 T3 5.11 (.71) 4.14 (1.15)
 T4 5.06 (.98) 4.40 (1.22)
Patient Health Questionnaire-9
 T1 9.36 (5.99) 10.48 (6.54)
 T2 9.15 (5.71) 9.54 (5.71)
 T3 9.49 (5.25) 8.05 (5.12)
 T4 7.61 (4.73) 7.85 (5.34)
Five Facet Mindfulness Questionnaire
 T1 122.35 (21.72) 127.91(20.67)
 T2 125.43 (22.75) 130.04 (22.81)
 T3 132.19 (20.20) 130.56 (22.37)
 T4 132.94 (23.55) 132.98 (22.79)
Pain Catastrophizing Scale
 T1 21.69 (11.77) 19.26 (12.16)
 T2 20.09 (10.57) 19.19 (11.54)
 T3 15.00 (11.08) 17.60 (11.81)
 T4 16.28 (12.09) 14.73 (11.11)
Neuropathic Pain Symptom Inventory
 T1 0.40 (0.17) 0.43 (0.16)
 T2 0.42 (0.17) 0.42 (0.16)
 T3 0.37 (0.14) 0.39 (0.18)
 T4 0.37 (0.16) 0.37 (0.17)
Short-Form-12 Health Survey-physical health T-score
 T1 32.49 (10.15) 35.19 (10.38)
 T2 33.99 (9.61) 36.17 (10.27)
 T3 37.59 (10.25) 35.10 (10.56)
 T4 36.36 (12.22) 37.21 (12.20)
Short-Form-12 Health Survey-mental health T-score
 T1 43.07 (12.13) 46.64 (10.95)
 T2 45.94 (12.78) 47.06 (11.10)
 T3 48.17 (10.37) 46.69 (11.16)
 T4 48.98 (10.69) 48.44 (10.96)

T1: before medical optimization; T2: after randomization; T3: 2 weeks post-MBSR (and equivalent time point for waitlist control group); T4: 3 months post-MBSR (and equivalent time point for waitlist control group).